Matches in SemOpenAlex for { <https://semopenalex.org/work/W188630774> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W188630774 endingPage "825" @default.
- W188630774 startingPage "820" @default.
- W188630774 abstract "In view of studies showing that interferon alfa was effective treatment for chronic myeloid leukemia and that it prolonged survival, we organized a prospective, controlled comparative study of this treatment.We compared recombinant interferon alfa-2a with conventional chemotherapy (hydroxyurea or busulfan) in a trial designed to have a power of 80 percent to detect a difference of 20 percent in median survival between the group given interferon and the group given conventional chemotherapy. Between 1986 and 1988, 322 patients with previously untreated or minimally treated Philadelphia chromosome-positive chronic myeloid leukemia were randomly assigned to treatment with either interferon alfa-2a (218 patients) or conventional chemotherapy (104 patients).The rate of karyotypic response (defined as > 33 percent of metaphases negative for the Philadelphia chromosome) was 30 percent in the interferon group and 5 percent in the conventional-chemotherapy group (P < 0.001). The time to progression from the chronic phase of leukemia to an accelerated or a blastic phase was longer in the interferon group than in the conventional-chemotherapy group (median, > 72 vs. 45 months; P < 0.001), as was survival (median, 72 vs. 52 months; 6-year survival, 50 percent vs. 29 percent; P = 0.002 for both comparisons). There was one treatment-related death in each group. Treatment was discontinued because of side effects (mainly influenza-like, gastrointestinal, or neurologic symptoms) in 35 patients given interferon alfa-2a (16 percent). The cost of interferon treatment was 200 times that of the conventional treatment.During long-term treatment of Philadelphia chromosome-positive chronic myeloid leukemia, interferon alfa-2a induced more karyotypic responses than conventional chemotherapy, delayed disease progression longer, and prolonged overall survival more." @default.
- W188630774 created "2016-06-24" @default.
- W188630774 date "1994-03-24" @default.
- W188630774 modified "2023-10-12" @default.
- W188630774 title "Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia" @default.
- W188630774 cites W2038252730 @default.
- W188630774 cites W2089697181 @default.
- W188630774 cites W2164088012 @default.
- W188630774 cites W2269564684 @default.
- W188630774 cites W2337803710 @default.
- W188630774 cites W2402092920 @default.
- W188630774 cites W2414556975 @default.
- W188630774 cites W2587781815 @default.
- W188630774 cites W3041047318 @default.
- W188630774 cites W4233157183 @default.
- W188630774 doi "https://doi.org/10.1056/nejm199403243301204" @default.
- W188630774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8114834" @default.
- W188630774 hasPublicationYear "1994" @default.
- W188630774 type Work @default.
- W188630774 sameAs 188630774 @default.
- W188630774 citedByCount "548" @default.
- W188630774 countsByYear W1886307742012 @default.
- W188630774 countsByYear W1886307742013 @default.
- W188630774 countsByYear W1886307742014 @default.
- W188630774 countsByYear W1886307742015 @default.
- W188630774 countsByYear W1886307742016 @default.
- W188630774 countsByYear W1886307742017 @default.
- W188630774 countsByYear W1886307742018 @default.
- W188630774 countsByYear W1886307742019 @default.
- W188630774 countsByYear W1886307742020 @default.
- W188630774 countsByYear W1886307742021 @default.
- W188630774 countsByYear W1886307742022 @default.
- W188630774 countsByYear W1886307742023 @default.
- W188630774 crossrefType "journal-article" @default.
- W188630774 hasBestOaLocation W1886307741 @default.
- W188630774 hasConcept C104317684 @default.
- W188630774 hasConcept C126322002 @default.
- W188630774 hasConcept C138626823 @default.
- W188630774 hasConcept C141071460 @default.
- W188630774 hasConcept C143998085 @default.
- W188630774 hasConcept C185592680 @default.
- W188630774 hasConcept C203014093 @default.
- W188630774 hasConcept C2776178377 @default.
- W188630774 hasConcept C2776694085 @default.
- W188630774 hasConcept C2776755627 @default.
- W188630774 hasConcept C2778461978 @default.
- W188630774 hasConcept C2778729363 @default.
- W188630774 hasConcept C2778904597 @default.
- W188630774 hasConcept C2780611847 @default.
- W188630774 hasConcept C2781228144 @default.
- W188630774 hasConcept C2909179924 @default.
- W188630774 hasConcept C55493867 @default.
- W188630774 hasConcept C71924100 @default.
- W188630774 hasConcept C90924648 @default.
- W188630774 hasConceptScore W188630774C104317684 @default.
- W188630774 hasConceptScore W188630774C126322002 @default.
- W188630774 hasConceptScore W188630774C138626823 @default.
- W188630774 hasConceptScore W188630774C141071460 @default.
- W188630774 hasConceptScore W188630774C143998085 @default.
- W188630774 hasConceptScore W188630774C185592680 @default.
- W188630774 hasConceptScore W188630774C203014093 @default.
- W188630774 hasConceptScore W188630774C2776178377 @default.
- W188630774 hasConceptScore W188630774C2776694085 @default.
- W188630774 hasConceptScore W188630774C2776755627 @default.
- W188630774 hasConceptScore W188630774C2778461978 @default.
- W188630774 hasConceptScore W188630774C2778729363 @default.
- W188630774 hasConceptScore W188630774C2778904597 @default.
- W188630774 hasConceptScore W188630774C2780611847 @default.
- W188630774 hasConceptScore W188630774C2781228144 @default.
- W188630774 hasConceptScore W188630774C2909179924 @default.
- W188630774 hasConceptScore W188630774C55493867 @default.
- W188630774 hasConceptScore W188630774C71924100 @default.
- W188630774 hasConceptScore W188630774C90924648 @default.
- W188630774 hasIssue "12" @default.
- W188630774 hasLocation W1886307741 @default.
- W188630774 hasLocation W1886307742 @default.
- W188630774 hasOpenAccess W188630774 @default.
- W188630774 hasPrimaryLocation W1886307741 @default.
- W188630774 hasRelatedWork W13741169 @default.
- W188630774 hasRelatedWork W2021005164 @default.
- W188630774 hasRelatedWork W2126479366 @default.
- W188630774 hasRelatedWork W2151306763 @default.
- W188630774 hasRelatedWork W2411769263 @default.
- W188630774 hasRelatedWork W2416023926 @default.
- W188630774 hasRelatedWork W2427268638 @default.
- W188630774 hasRelatedWork W2461318346 @default.
- W188630774 hasRelatedWork W2742933893 @default.
- W188630774 hasRelatedWork W862678944 @default.
- W188630774 hasVolume "330" @default.
- W188630774 isParatext "false" @default.
- W188630774 isRetracted "false" @default.
- W188630774 magId "188630774" @default.
- W188630774 workType "article" @default.